Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
03 2월 2025 - 10:00PM
Integer Holdings Corporation (NYSE: ITGR), a leading global medical
device contract development and manufacturing organization (CDMO),
will join innovators and industry leaders around the world in
exhibiting at MD&M West, Feb. 4 – 6, 2025, at the Anaheim
Convention Center in Anaheim, California.
Integer welcomes visitors to booth #1439 to learn more about the
company’s commitment to customers as their partner of choice in
enhancing the lives of patients through access to innovative
technologies, superior quality and dependable manufacturing to
accelerate speed to market and reduce product development risk.
Integer’s exhibit will showcase capabilities and solutions to
enable cardio and vascular, cardiac rhythm management and
neuromodulation products, and how the company blends technology,
expertise and resources to amplify customers’
innovation.
Integer will additionally highlight its global rapid prototyping
services that enable customers’ direct access to a team of
dedicated experts in R&D and engineering. With a local-to-local
approach and as little as a two-week turnaround, customers now can
obtain rapid prototypes in specialized cardiovascular markets,
including structural heart, electrophysiology and neurovascular.
Offerings include catheter shafts and guidewires, steerable
sheaths, introducers, braiding and textiles, and machined
components.
“As we expand our capabilities and capacity through ongoing
strategic investments, we will continue to anticipate our
customers’ needs in a highly innovative and rapidly evolving
medical device landscape,” said Payman Khales, President, Cardio
and Vascular. “We look forward to demonstrating our collaborative
approach, continued commitment to innovation, and the strategic
value we provide as our customers’ trusted and reliable end-to-end
partner in medical device technologies.”
Integer will also showcase a range of key product areas
throughout the event, including:
- Cardiac rhythm management and
neuromodulation: Miniaturized technology for finished IPGs as well
as Gen 3 Li Ion and Gen 2 CFx batteries.
- Cardio and vascular solutions: A
full range of electrophysiology, structural heart, and
neurovascular product solutions including complex catheters,
high-performing guidewires, steerable introducers and sheaths,
therapy delivery systems, and implant technologies.
In addition to Integer’s exhibit at booth #1439, MD&M West
2025 attendees can visit Pulse Technologies, an Integer Company, at
booth #2854 to learn more about HSR technology and complex micro
machining for critical medical device components.
Attendees are also invited to visit Precision Coating at booth
#2269. Integer acquired substantially all of the assets of
Precision Coating, a privately held manufacturer specializing in
high value surface coating technology platforms, including
fluoropolymer, anodic coatings, ion treatment solutions and laser
processing, on Jan. 7, 2025, for $152 million, subject to
adjustment for additional contingent consideration. Consistent with
Integer’s tuck-in acquisition strategy, the acquisition of
Precision Coating increases Integer’s service offerings to include
differentiated and proprietary coatings capabilities that position
Integer to better meet customers’ evolving needs.
Integer will share additional details on this acquisition during
its fourth quarter and full year 2024 earnings call on Feb. 20,
2025.
Learn more about Integer at www.integer.net.
About
Integer®Integer Holdings
Corporation (NYSE: ITGR) is one of the largest medical device
contract development and manufacturing organizations (CDMO) in the
world, serving the cardiac rhythm management, neuromodulation, and
cardio and vascular markets. As a strategic partner of choice to
medical device companies and OEMs, the Company is committed to
enhancing the lives of patients worldwide by providing innovative,
high-quality products and solutions. The Company's brands include
Greatbatch Medical® and Lake Region Medical®. Additional
information is available at www.integer.net.
Investor Relations: |
Media
Relations: |
Andrew Senn |
Kelly Butler |
andrew.senn@integer.net |
kelly.butler@integer.net |
763.951.8312 |
469.731.6617 |
Integer (NYSE:ITGR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
Integer (NYSE:ITGR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025